Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
MedGenome Labs Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. SARS-COV2 patients (positive PCR of any specimen) presenting with pneumonia (evidenced by chest X ray or CT scan) 2. Patients >18 years and 3. Patients of either gender
Exclusion criteria
Exclusion criteria: 1. NAAT tested Negative for COVID-19 by PCR 2. Patients 69 years Old 3. Patients unwilling or unable to consent to participate in the study 4. HIV positive patients 5. Immuno-compromised Patients 6. Patients with underlying autoimmune diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Building an Indian SARS-CoV2 Host Genetics Consortium â?? Collect samples from SARS-CoV2 patients with high quality clinical metadata across India to capture diverse genetic and demographic backgrounds from multiple collaborating hospital sitesTimepoint: 1ST YEAR | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Immunogenetic Data Generation â?? Create a shared resource of SARS-CoV2 clinical phenotypes and molecular biomarkers, including genetic, immunogenetic, gene expression profiles. 2.Predictive Biomarker Identification and Application â?? Identify potential predictive biomarkers for disease severity, progression, and outcome using advanced bioinformatics and big data machine learning techniques.Timepoint: 2nd Year | — |
Countries
India
Contacts
Public ContactDr Alben Sigamani
NH Narayana Health
Outcome results
None listed